Dermata Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DRMAW | DERM | SNOA | MANE | SKIN | TEVA | |
|---|---|---|---|---|---|---|
| Market cap | — | 144.23M | 5.33M | 4.92B | 69.10M | 48.25B |
| P/E (TTM) | — | — | — | — | — | 69.0 |
| Forward P/E | — | -85.2 | -2.0 | -43.7 | 2.8 | 13.4 |
| Price/book | 0.0 | 4.4 | 0.8 | 6.0 | 1.2 | 6.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | — | −31.33% | −71.57% | +188.26% | −62.01% | +113.70% |
| Today | −50.00% | +2.92% | −0.63% | +8.16% | +0.57% | −0.31% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All DRMAW news ›Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
- Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments - - Over 71% of study participants were graded as having overall improvements in their skin after only one…
Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive Topline Results from Cosmetic Study
Dermata Therapeutics (NASDAQ:DRMA) jumps over 44% after positive topline results from a cosmetic study of its once-weekly Tome Foundational Treatment. Skin in the Game for Dermata Therapeutics, Inc. (NASDAQ:DRMA) Big Gains on Positive…
Dermata Therapeutics, Inc. (DRMA) Reports Positive Tome Cosmetic Study Results
Dermata Therapeutics, Inc. (DRMA) Reports Positive Cosmetic Study Results for Tome TradingView Dermata Therapeutics, Inc. (DRMA) Reports Positive Tome Cosmetic Study Results Dermata reported positive topline results from an open-label…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
investorideas.com1
-
stocktitan.net1
-
tradingview.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.